Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cephalon Gabitril REMS gets FDA approval
Gabitril is indicated as an adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures. The Gabitril REMS consists of a Medication
Gabitril is indicated as an adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures. The Gabitril REMS consists of a Medication
Through its FDA approval, Gamunex-C becomes the first and only immunoglobulin therapy approved in the US with both intravenous and subcutaneous routes of administration to treat PI, Talecris
Curtis brings to Catabasis more than 19 years of experience in the pharmaceutical and biotechnology industries, and has been integrally involved in the development of over 15 compounds
Prolong president Glenn Kazo said that as they move towards the clinic with Sanguinate product they are pleased to receive this level of financing for the next phase
The award is to advance the product development and commercialisation of its topical Albuterpenoid drug, a patented anti-viral therapeutic derived from East Indian Sandalwood oil (EISO), aimed at
The new AF2 facility has been designed to meet cGMP (Current Good Manufacturing Practice) requirements, to deliver a new standard for safety and quality for cell culture media
As part of the partnership, PDR Network will work with The Doctors Company to facilitate the integration of CME into REMS programs, independently evaluating the clinical, patient-safety-focused information
As part of the initiatives, Eden Prairie, Minnesota-based SurModics is reducing its total workforce by approximately 13%. The company will implement an organisational structure that reflects its three
Data presented at the Annual Congress of the European Association of Nuclear Medicine in Vienna demonstrated that Trofex rapidly detected prostate cancer localised in the prostate bed, soft
The increase was attributable primarily to Cubist’s net sales of Cubicin (daptomycin for injection) in the US, which increased 12% to $154.5m in the third quarter of 2010